Report
Julie Boote ...
  • Pelham Smithers

PSA Today June 4: Flat / Pharma reviewed / The internet sector and anti-trust issues / US May auto sales stabilise – Nikkei -0.01%

Japan Market Comment by Pelham Smithers and Julie Boote
Nikkei ¥20,408.54 (-¥2.34 / -0.01%); Topix ¥1,499.09 (+¥0.13 / +0.01%); ¥/$107.95
Tags: Astellas Pharma (4503 JT), Seattle Genetics (SGEN US), Shionogi & Co (4507 JT), Roche (ROG SW), Ono Pharmaceutical (4528 JT), Merck (MRK US), Eisai (4523 JT), Chugai Pharmaceutical (4519 JT), Takeda Pharmaceutical (4502 JT), Daiichi Sankyo (4568 JT), AstraZeneca (AZN LN), Otsuka Holdings (4578 JT), Gilead (GILD US), CyberAgent (4751 JT), Mercari Inc (4385 JT), Recruit Holdings (6098 JT), ZOZO Inc (3092 JT), Facebook (FB US), Rakuten Inc (4755 JT), Apple (AAPL US), Google (GOOG US), Amazon (AMZN US), Kitanotatsujin (2930 JT), iStyle Inc (3668), Onward Holdings (8016 JT), Toyota (7203 JT), Subaru (7270 JT), Mazda (7261 JT), Mitsubishi Motors (7211 JT), Honda (7267 JT), Nissan (7201 JT)
Main Points
• Market flat as wait-and-see attitude takes hold
• Pharma in the news
• Might Japan also have an anti-trust problem in its internet sector?
• US auto market stabilises in May, Toyota and Subaru gain
Provider
Pelham Smithers Associates Ltd
Pelham Smithers Associates Ltd

Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods. 

PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries. 

The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012. 

Analysts
Julie Boote

Pelham Smithers

Other Reports from Pelham Smithers Associates Ltd

ResearchPool Subscriptions

Get the most out of your insights

Get in touch